Go Pro
→ Here’s the stock symbol I’ve promised (From Stansberry Research) (Ad)tc pixel Free RENX Stock Alerts

Renalytix (RENX) Competitors

Renalytix logo
GBX 2.80 +0.15 (+5.66%)
As of 11:03 AM Eastern
Compare

RENX vs. COG, INHC, FDBK, IQAI, and DVRG

Should you buy Renalytix stock or one of its competitors? MarketBeat compares Renalytix with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Renalytix include Cambridge Cognition (COG), Induction Healthcare Group (INHC), Feedback (FDBK), IQ-AI (IQAI), and DeepVerge (DVRG). These companies are all part of the "health information services" industry.

How does Renalytix compare to Cambridge Cognition?

Renalytix (LON:RENX) and Cambridge Cognition (LON:COG) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitability, risk, earnings, analyst recommendations, institutional ownership, valuation and media sentiment.

Cambridge Cognition has a net margin of -17.82% compared to Renalytix's net margin of -506.25%. Renalytix's return on equity of 675.00% beat Cambridge Cognition's return on equity.

Company Net Margins Return on Equity Return on Assets
Renalytix-506.25% 675.00% -93.54%
Cambridge Cognition -17.82%-62.89%-0.30%

Cambridge Cognition has higher revenue and earnings than Renalytix. Cambridge Cognition is trading at a lower price-to-earnings ratio than Renalytix, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Renalytix£3.30M3.71-£109.93M-£4.00N/A
Cambridge Cognition£9.40M1.83-£1.58M-£3.90N/A

In the previous week, Renalytix's average media sentiment score of 0.00 equaled Cambridge Cognition'saverage media sentiment score.

Company Overall Sentiment
Renalytix Neutral
Cambridge Cognition Neutral

Renalytix has a beta of 1.79, suggesting that its share price is 79% more volatile than the broader market. Comparatively, Cambridge Cognition has a beta of 0.804, suggesting that its share price is 20% less volatile than the broader market.

14.0% of Renalytix shares are held by institutional investors. Comparatively, 15.9% of Cambridge Cognition shares are held by institutional investors. 5.1% of Renalytix shares are held by company insiders. Comparatively, 2.8% of Cambridge Cognition shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Cambridge Cognition has a consensus price target of GBX 56, indicating a potential upside of 74.86%. Given Cambridge Cognition's stronger consensus rating and higher probable upside, analysts plainly believe Cambridge Cognition is more favorable than Renalytix.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Renalytix
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Cambridge Cognition
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Summary

Cambridge Cognition beats Renalytix on 9 of the 14 factors compared between the two stocks.

How does Renalytix compare to Induction Healthcare Group?

Induction Healthcare Group (LON:INHC) and Renalytix (LON:RENX) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, media sentiment, valuation, risk, institutional ownership, profitability, analyst recommendations and dividends.

In the previous week, Induction Healthcare Group's average media sentiment score of 0.00 equaled Renalytix'saverage media sentiment score.

Company Overall Sentiment
Induction Healthcare Group Neutral
Renalytix Neutral

Induction Healthcare Group has a beta of -0.41, indicating that its stock price is 141% less volatile than the broader market. Comparatively, Renalytix has a beta of 1.79, indicating that its stock price is 79% more volatile than the broader market.

46.3% of Induction Healthcare Group shares are owned by institutional investors. Comparatively, 14.0% of Renalytix shares are owned by institutional investors. 54.6% of Induction Healthcare Group shares are owned by insiders. Comparatively, 5.1% of Renalytix shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Induction Healthcare Group has higher revenue and earnings than Renalytix. Induction Healthcare Group is trading at a lower price-to-earnings ratio than Renalytix, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Induction Healthcare Group£12.57M0.72-£5.12M-£5.54N/A
Renalytix£3.30M3.71-£109.93M-£4.00N/A

Induction Healthcare Group has a net margin of -23.86% compared to Renalytix's net margin of -506.25%. Renalytix's return on equity of 675.00% beat Induction Healthcare Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Induction Healthcare Group-23.86% -14.58% -7.32%
Renalytix -506.25%675.00%-93.54%

Summary

Induction Healthcare Group beats Renalytix on 6 of the 11 factors compared between the two stocks.

How does Renalytix compare to Feedback?

Feedback (LON:FDBK) and Renalytix (LON:RENX) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, dividends, risk, institutional ownership, valuation, profitability, media sentiment and analyst recommendations.

In the previous week, Feedback's average media sentiment score of 0.00 equaled Renalytix'saverage media sentiment score.

Company Overall Sentiment
Feedback Neutral
Renalytix Neutral

Feedback has a beta of 0.77, meaning that its share price is 23% less volatile than the broader market. Comparatively, Renalytix has a beta of 1.79, meaning that its share price is 79% more volatile than the broader market.

Feedback has higher earnings, but lower revenue than Renalytix. Renalytix is trading at a lower price-to-earnings ratio than Feedback, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Feedback£849.62K3.13-£10.84M-£15.74N/A
Renalytix£3.30M3.71-£109.93M-£4.00N/A

Renalytix has a net margin of -506.25% compared to Feedback's net margin of -845.25%. Renalytix's return on equity of 675.00% beat Feedback's return on equity.

Company Net Margins Return on Equity Return on Assets
Feedback-845.25% -135.17% -22.99%
Renalytix -506.25%675.00%-93.54%

34.2% of Feedback shares are held by institutional investors. Comparatively, 14.0% of Renalytix shares are held by institutional investors. 8.0% of Feedback shares are held by company insiders. Comparatively, 5.1% of Renalytix shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

Renalytix beats Feedback on 6 of the 11 factors compared between the two stocks.

How does Renalytix compare to IQ-AI?

IQ-AI (LON:IQAI) and Renalytix (LON:RENX) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, risk, dividends, earnings, institutional ownership, analyst recommendations, valuation and media sentiment.

IQ-AI has a beta of 2.25, meaning that its share price is 125% more volatile than the broader market. Comparatively, Renalytix has a beta of 1.79, meaning that its share price is 79% more volatile than the broader market.

In the previous week, IQ-AI's average media sentiment score of 0.00 equaled Renalytix'saverage media sentiment score.

Company Overall Sentiment
IQ-AI Neutral
Renalytix Neutral

14.0% of Renalytix shares are owned by institutional investors. 66.0% of IQ-AI shares are owned by company insiders. Comparatively, 5.1% of Renalytix shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

IQ-AI has higher earnings, but lower revenue than Renalytix.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
IQ-AI£538.19K3.30N/AN/AN/A
Renalytix£3.30M3.71-£109.93M-£4.00N/A

IQ-AI has a net margin of -77.52% compared to Renalytix's net margin of -506.25%. Renalytix's return on equity of 675.00% beat IQ-AI's return on equity.

Company Net Margins Return on Equity Return on Assets
IQ-AI-77.52% -140.75% -22.03%
Renalytix -506.25%675.00%-93.54%

Summary

Renalytix beats IQ-AI on 5 of the 9 factors compared between the two stocks.

How does Renalytix compare to DeepVerge?

Renalytix (LON:RENX) and DeepVerge (LON:DVRG) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their earnings, valuation, risk, institutional ownership, dividends, profitability, media sentiment and analyst recommendations.

Renalytix has a beta of 1.79, indicating that its share price is 79% more volatile than the broader market. Comparatively, DeepVerge has a beta of 1.07, indicating that its share price is 7% more volatile than the broader market.

DeepVerge has a net margin of -19.81% compared to Renalytix's net margin of -506.25%. Renalytix's return on equity of 675.00% beat DeepVerge's return on equity.

Company Net Margins Return on Equity Return on Assets
Renalytix-506.25% 675.00% -93.54%
DeepVerge -19.81%-10.27%-5.56%

DeepVerge has higher revenue and earnings than Renalytix. Renalytix is trading at a lower price-to-earnings ratio than DeepVerge, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Renalytix£3.30M3.71-£109.93M-£4.00N/A
DeepVerge£12.41M0.00-£2.46M-£0.01N/A

In the previous week, Renalytix's average media sentiment score of 0.00 equaled DeepVerge'saverage media sentiment score.

Company Overall Sentiment
Renalytix Neutral
DeepVerge Neutral

14.0% of Renalytix shares are owned by institutional investors. Comparatively, 4.2% of DeepVerge shares are owned by institutional investors. 5.1% of Renalytix shares are owned by insiders. Comparatively, 9.5% of DeepVerge shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

DeepVerge beats Renalytix on 6 of the 10 factors compared between the two stocks.

Get Renalytix News Delivered to You Automatically

Sign up to receive the latest news and ratings for RENX and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

RENX vs. The Competition

Export
MetricRenalytixHealth Information Services IndustryMedical SectorLON Exchange
Market Cap£12.24M£916.40M£7.04B£2.82B
Dividend YieldN/A6.06%2.67%6.15%
P/E Ratio-0.70301.2327.27368.03
Price / Sales3.71142.33492.2783,988.05
Price / Cash1.8447.1426.3927.89
Price / Book-0.267.9310.387.36
Net Income-£109.93M-£22.78M£3.60B£5.89B
7 Day Performance4.63%0.73%-1.87%0.36%
1 Month Performance48.94%-1.75%-2.81%0.38%
1 Year Performance-60.56%-10.30%17.84%67.70%

Renalytix Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
RENX
Renalytix
N/AGBX 2.80
+5.7%		N/A-60.7%£12.24M£3.30MN/A102
COG
Cambridge Cognition
N/AGBX 31.25
-0.8%		GBX 56
+79.2%		-0.7%£16.82M£9.40MN/A80
INHC
Induction Healthcare Group
N/AGBX 9.75
flat		N/A+0.0%£9.00M£12.57MN/A74
FDBK
Feedback
N/AGBX 6.30
+0.8%		N/A-56.9%£2.74M£849.62KN/A24
IQAI
IQ-AI
N/AGBX 0.80
flat		N/A+0.0%£1.77M£538.19KN/A6

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (LON:RENX) was last updated on 7/28/2026 by MarketBeat.com Staff.
From Our Partners
My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...
The Oxford Club | Sponsoredtc pixel
SpaceX pays a 10X launch penalty
SpaceX burns roughly $200,000 in fuel per Falcon 9 launch - about $20 million across 100 missions. One unde...
Freedom Financial | Sponsoredtc pixel
A 50-year dollar arrangement just ended - what it means for you
In 1974, Henry Kissinger helped create the U.S.-Saudi Arabia Joint Commission on Economic Cooperation - a litt...
Golden Portfolio | Sponsoredtc pixel
Buy this stock today
Marc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...
Chaikin Analytics | Sponsoredtc pixel
What Elon told his top shareholders in Texas
Late last year, Elon Musk gathered top shareholders at Tesla's Texas Gigafactory to unveil a plan to double Am...
Banyan Hill Publishing | Sponsoredtc pixel
Trump’s emergency dollar reset
Bloomberg research shows the U.S. dollar's share of global reserves has fallen to the lowest level this centur...
Porter & Company | Sponsoredtc pixel
Trump’s $250 Bill – See Immediately
Former Goldman Sachs VP Dr. David Eifrig is warning that July 28 could trigger the biggest wealth reset in mod...
Stansberry Research | Sponsoredtc pixel
Three oil giants buried the same discovery for 50 years
In 1976, Chevron tapped an energy source with no fuel costs, no carbon, and no supply chain - then killed the ...
Behind the Markets | Sponsoredtc pixel